ANI Pharmaceuticals Launches Pimozide Tablets in Two Dosages
ANI Pharmaceuticals (ANIP) announced the launch of its generic version of Orap® as Pimozide Tablets at 1 mg and 2 mg dosages. The company also reported US annual sales for this product to be approximately $3.1 million based on February 2026 IQVIA data.
Tickers: $ANIP
Topics: generic_drugs pharmaceuticals product_launch sales_data